Association between mifepristone dose, efficacy, and tolerability in patients with Cushing syndrome.

October 21, 2015

Yuen et al. • 2015 • Endocr Pract. 2015;21(10):1087-92.

Long-Term Follow-Up in Adrenal Incidentalomas: An Italian Multicenter Study

November 15, 2014

Morelli et al • 2014 • J Clin Endocrinol Metab.

Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas

November 10, 2014

Debono et al • 2014 • J Clin Endocrinol Metab.

Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing’s syndrome.

April 15, 2012

Fleseriu et al. • 2012 • J Clin Endocrinol Metab. 2012;97(6):2039-49.